Concurrent evaluation of p53, β-catenin, and α-fetoprotein expression in human hepatocellular carcinoma

Michael Torbenson, Rajesh Kannangai, Susan Abraham, Fikret Sahin, Michael Choti, Jianzhou Wang

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Recent models suggest that hepatocellular carcinoma (HCC) develops through several independent pathways marked by key mutations in the β-catenin or p53 gene. An additional pathway potentially is marked by aberrant expression of a-fetoprotein (AFP). To see whether these potential markers are expressed independently, we immunostained sequential sections from 55 HCCs. Of the cases, 30 (55%) were positive for 1 or more proteins: AFP, 19 cases (35%); p53, 12 cases (22%); and β-catenin, 9 cases (16%). Seven tumors (13%) were positive for more than 1 protein, with 4 of 7 positive in the same area of tumor and 3 of 7 positive in different areas of the carcinomas. By statistical analysis, expression of the markers was independent of one another and of tumor size. Concurrent evaluation of p53, β-catenin, and AFP protein expression showed no associations, supporting models in which these proteins might serve as markers of independent pathways in the development of HCC.

Original languageEnglish (US)
Pages (from-to)377-382
Number of pages6
JournalAmerican Journal of Clinical Pathology
Volume122
Issue number3
DOIs
StatePublished - Sep 2004

Fingerprint

Fetal Proteins
Catenins
Hepatocellular Carcinoma
Proteins
Neoplasms
p53 Genes
Carcinoma
Mutation

Keywords

  • α-Fetoprotein
  • β-Catenin
  • Hepatocellular carcinoma
  • P53

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Concurrent evaluation of p53, β-catenin, and α-fetoprotein expression in human hepatocellular carcinoma. / Torbenson, Michael; Kannangai, Rajesh; Abraham, Susan; Sahin, Fikret; Choti, Michael; Wang, Jianzhou.

In: American Journal of Clinical Pathology, Vol. 122, No. 3, 09.2004, p. 377-382.

Research output: Contribution to journalArticle

Torbenson, Michael ; Kannangai, Rajesh ; Abraham, Susan ; Sahin, Fikret ; Choti, Michael ; Wang, Jianzhou. / Concurrent evaluation of p53, β-catenin, and α-fetoprotein expression in human hepatocellular carcinoma. In: American Journal of Clinical Pathology. 2004 ; Vol. 122, No. 3. pp. 377-382.
@article{dbbb71d0aa9b45e087b424be1d2f90f1,
title = "Concurrent evaluation of p53, β-catenin, and α-fetoprotein expression in human hepatocellular carcinoma",
abstract = "Recent models suggest that hepatocellular carcinoma (HCC) develops through several independent pathways marked by key mutations in the β-catenin or p53 gene. An additional pathway potentially is marked by aberrant expression of a-fetoprotein (AFP). To see whether these potential markers are expressed independently, we immunostained sequential sections from 55 HCCs. Of the cases, 30 (55{\%}) were positive for 1 or more proteins: AFP, 19 cases (35{\%}); p53, 12 cases (22{\%}); and β-catenin, 9 cases (16{\%}). Seven tumors (13{\%}) were positive for more than 1 protein, with 4 of 7 positive in the same area of tumor and 3 of 7 positive in different areas of the carcinomas. By statistical analysis, expression of the markers was independent of one another and of tumor size. Concurrent evaluation of p53, β-catenin, and AFP protein expression showed no associations, supporting models in which these proteins might serve as markers of independent pathways in the development of HCC.",
keywords = "α-Fetoprotein, β-Catenin, Hepatocellular carcinoma, P53",
author = "Michael Torbenson and Rajesh Kannangai and Susan Abraham and Fikret Sahin and Michael Choti and Jianzhou Wang",
year = "2004",
month = "9",
doi = "10.1309/YH0H-3FKY-M4RM-U1JF",
language = "English (US)",
volume = "122",
pages = "377--382",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "3",

}

TY - JOUR

T1 - Concurrent evaluation of p53, β-catenin, and α-fetoprotein expression in human hepatocellular carcinoma

AU - Torbenson, Michael

AU - Kannangai, Rajesh

AU - Abraham, Susan

AU - Sahin, Fikret

AU - Choti, Michael

AU - Wang, Jianzhou

PY - 2004/9

Y1 - 2004/9

N2 - Recent models suggest that hepatocellular carcinoma (HCC) develops through several independent pathways marked by key mutations in the β-catenin or p53 gene. An additional pathway potentially is marked by aberrant expression of a-fetoprotein (AFP). To see whether these potential markers are expressed independently, we immunostained sequential sections from 55 HCCs. Of the cases, 30 (55%) were positive for 1 or more proteins: AFP, 19 cases (35%); p53, 12 cases (22%); and β-catenin, 9 cases (16%). Seven tumors (13%) were positive for more than 1 protein, with 4 of 7 positive in the same area of tumor and 3 of 7 positive in different areas of the carcinomas. By statistical analysis, expression of the markers was independent of one another and of tumor size. Concurrent evaluation of p53, β-catenin, and AFP protein expression showed no associations, supporting models in which these proteins might serve as markers of independent pathways in the development of HCC.

AB - Recent models suggest that hepatocellular carcinoma (HCC) develops through several independent pathways marked by key mutations in the β-catenin or p53 gene. An additional pathway potentially is marked by aberrant expression of a-fetoprotein (AFP). To see whether these potential markers are expressed independently, we immunostained sequential sections from 55 HCCs. Of the cases, 30 (55%) were positive for 1 or more proteins: AFP, 19 cases (35%); p53, 12 cases (22%); and β-catenin, 9 cases (16%). Seven tumors (13%) were positive for more than 1 protein, with 4 of 7 positive in the same area of tumor and 3 of 7 positive in different areas of the carcinomas. By statistical analysis, expression of the markers was independent of one another and of tumor size. Concurrent evaluation of p53, β-catenin, and AFP protein expression showed no associations, supporting models in which these proteins might serve as markers of independent pathways in the development of HCC.

KW - α-Fetoprotein

KW - β-Catenin

KW - Hepatocellular carcinoma

KW - P53

UR - http://www.scopus.com/inward/record.url?scp=4344675090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344675090&partnerID=8YFLogxK

U2 - 10.1309/YH0H-3FKY-M4RM-U1JF

DO - 10.1309/YH0H-3FKY-M4RM-U1JF

M3 - Article

C2 - 15362367

AN - SCOPUS:4344675090

VL - 122

SP - 377

EP - 382

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 3

ER -